Results 121 to 130 of about 11,356 (158)
Some of the next articles are maybe not open access.
Archives of Ophthalmology, 1984
In Reply. —The Ophthalmology Journal Club's inquiries are answerable by perusal of our article, by review of the previous literature, and by analysis of some unpublished data. All patients admitted to the University of Illinois Eye and Ear Infirmary, Chicago, with traumatic hyphema were placed on the study protocol, while the hyphema was active, if ...
Marilyn D. Farber +4 more
openaire +2 more sources
In Reply. —The Ophthalmology Journal Club's inquiries are answerable by perusal of our article, by review of the previous literature, and by analysis of some unpublished data. All patients admitted to the University of Illinois Eye and Ear Infirmary, Chicago, with traumatic hyphema were placed on the study protocol, while the hyphema was active, if ...
Marilyn D. Farber +4 more
openaire +2 more sources
Epsilon-Aminocaproic Acid (EACA)
Seminars in Thrombosis and Hemostasis, 2008Epsilon-aminocaproic acid (EACA) is a synthetic inhibitor of the plasmin-plasminogen system. It is the only potent antifibrinolytic agent which is commercially available in the United States. Effective blood levels of the drug are readily obtainable with either oral or intravenous administration, with very high levels of the drug being found in the ...
James D. Griffin, Leonard Ellman
openaire +3 more sources
Seizure After Infusion of Aminocaproic Acid
JAMA: The Journal of the American Medical Association, 1978AMINOCAPROIC acid is a useful agent in the management of hemophilia, particularly following extensive dental manipulations. The drug is widely used, in large measure because toxic reactions, including gastrointenstinal disturbances, dizziness, tinnitus, malaise, headache, rash, and conjunctival and nasal suffusion, are mild and rarely encountered.
Hafiz R. Parray +2 more
openaire +3 more sources
Convulsions Induced by Aminocaproic Acid Infusion
DICP, 1989Aminocaproic acid is a widely used antifibrinolytic agent. Serious adverse effects associated with its use are rare, but we report on a patient with liver disease and cirrhosis who experienced a grand mal seizure during the intravenous administration of aminocaproic acid.
Reuben Rabinovici +3 more
openaire +3 more sources
Aminocaproic Acid Prophylaxis in Traumatic Hyphema
Ophthalmic Surgery, Lasers and Imaging Retina, 1990ABSTRACT Oral aminocaproic acid has been shown to be effective in clot stabilization and in the reduction of secondary bleeding rates in cases of traumatic hyphema. In a retrospective study of 105 patients treated during a 1-year period, we found the incidence of rebleeding in patients with traumatic hyphema who received aminocaproic acid ...
Thomas W. Wilson +2 more
openaire +3 more sources
Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid
Annals of Pharmacotherapy, 1997OBJECTIVE: To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA). CASE SUMMARY: A 33-year-old female patient with chronic granulocytic leukemia was treated with epsilon-ACA for approximately 3.5 months for thrombocytopenic bleeding. The initial dosage was 4 g po q6h.
Morel Rubinger, Beverly D Seymour
openaire +3 more sources
Thrombosis with Epsilon Aminocaproic Acid Therapy
American Journal of Clinical Pathology, 1971A patient with postoperative bleeding was treated with epsilon aminocaproic acid (EACA). Subsequent coagulation studies supported the diagnosis of intravascular coagulation and the patient subsequently developed renal failure due to glomerular thromboses.
Harvey R. Gralnick, Philip Greipp
openaire +3 more sources
Aminocaproic Acid in the Treatment of Traumatic Hyphema
American Journal of Ophthalmology, 1976Of 59 patients with traumatic hyphema studied prospectively, 32 received aminocaproic acid, an antifibrinolytic agent, to prevent secondary hemorrhage. The remaining 27 patients received placebo in an identical manner. Of the aminocaproic acid-treated patients, only one (3%) rebled, while nine patients (33%) receiving placebo suffered secondary ...
Earl R. Crouch, Marcel Frenkel
openaire +3 more sources
Effect of -Aminocaproic Acid on Postvitrectomy Hemorrhage
Archives of Ophthalmology, 1985We performed a prospective study involving 96 patients undergoing vitrectomy for proliferative diabetic retinopathy to determine the effect of epsilon-aminocaproic acid on the occurrence of postoperative intraocular hemorrhage. epsilon-Aminocaproic acid significantly reduced postoperative vitreous hemorrhage during the immediate postoperative period ...
S. De Bustros +3 more
openaire +3 more sources
Effect of probenecid on the kinetics of epsilon-aminocaproic acid
Clinical Pharmacology and Therapeutics, 1980Healthy male subjects received, 1 wk apart, single oral doses of epsilon-aminocaproic acid (EACA) 100 mg/kg alone, EACA within probenecid (0.5 gm), or EACA 2 hr after 2.0 gm probenecid. Probenecid (2.0 gm) reduced the 8-hr urinary clearance and recovery of EACA by 50% without affecting plasma kinetics.
Kerry L Katlic +3 more
openaire +3 more sources